Metabolites
Displaying compounds 3751 - 3775 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB12588 | CDP-DG(22:1(13Z)/28:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(12Z)-octacos-12-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H113N3O15P2 1202.54 | |
| YMDB12587 | CDP-DG(22:1(13Z)/28:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(octacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H115N3O15P2 1204.556 | |
| YMDB12586 | CDP-DG(22:1(13Z)/26:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(10Z)-heptacos-10-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C61H111N3O15P2 1188.513 | |
| YMDB12585 | CDP-DG(22:1(13Z)/26:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(12Z)-hexacos-12-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C60H109N3O15P2 1174.486 | |
| YMDB12584 | CDP-DG(22:1(13Z)/26:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(hexacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C60H111N3O15P2 1176.502 | |
| YMDB12583 | CDP-DG(22:1(13Z)/25:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(9Z)-pentacos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12582 | CDP-DG(22:1(13Z)/25:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(11Z)-pentacos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H107N3O15P2 1160.459 | |
| YMDB12581 | CDP-DG(22:1(13Z)/25:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(pentacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H109N3O15P2 1162.475 | |
| YMDB12580 | CDP-DG(22:1(13Z)/24:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(9Z)-tetracos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H105N3O15P2 1146.432 | |
| YMDB12579 | CDP-DG(22:1(13Z)/24:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(11Z)-tetracos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H105N3O15P2 1146.432 | |
| YMDB12578 | CDP-DG(22:1(13Z)/24:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-(tetracosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C58H107N3O15P2 1148.448 | |
| YMDB12577 | CDP-DG(22:1(13Z)/23:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(9Z)-tricos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C57H103N3O15P2 1132.405 | |
| YMDB12576 | CDP-DG(22:1(13Z)/23:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(11Z)-tricos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C57H103N3O15P2 1132.405 | |
| YMDB12575 | CDP-DG(22:1(13Z)/22:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-[(13Z)-docos-13-enoyloxy]-2-[(9Z)-docos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H101N3O15P2 1118.378 | |
| YMDB12574 | CDP-DG(22:1(13Z)/22:1(13Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-2,3-bis[(13Z)-docos-13-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C56H101N3O15P2 1118.378 | |
| YMDB12573 | CDP-DG(22:0/30:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-(triacontanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C64H121N3O15P2 1234.626 | |
| YMDB12572 | CDP-DG(22:0/28:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(10Z)-octacos-10-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H115N3O15P2 1204.556 | |
| YMDB12571 | CDP-DG(22:0/28:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(12Z)-octacos-12-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H115N3O15P2 1204.556 | |
| YMDB12570 | CDP-DG(22:0/28:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-(octacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C62H117N3O15P2 1206.572 | |
| YMDB12569 | CDP-DG(22:0/26:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(10Z)-heptacos-10-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C61H113N3O15P2 1190.529 | |
| YMDB12568 | CDP-DG(22:0/26:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(12Z)-hexacos-12-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C60H111N3O15P2 1176.502 | |
| YMDB12567 | CDP-DG(22:0/26:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-(hexacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C60H113N3O15P2 1178.518 | |
| YMDB12566 | CDP-DG(22:0/25:1(9Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(9Z)-pentacos-9-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H109N3O15P2 1162.475 | |
| YMDB12565 | CDP-DG(22:0/25:1(11Z)) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-[(11Z)-pentacos-11-enoyloxy]propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H109N3O15P2 1162.475 | |
| YMDB12564 | CDP-DG(22:0/25:0) | {[(2R,3R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[(2R)-3-(docosanoyloxy)-2-(pentacosanoyloxy)propoxy](hydroxy)phosphoryl}oxy)phosphinic acid | C59H111N3O15P2 1164.491 |